Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: A multi-center randomized trial

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 6, 2015, Pages 637-645

  Granese, Roberta ^a   Perino, Antonino ^b   Calagna, Gloria ^b   Saitta, Salvatore ^a   De Franciscis, Pasquale ^c   Colacurci, Nicola ^c   Triolo, Onofrio ^a   Cucinella, Gaspare ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

chronic pelvic pain; dienogest; Endometriosis; GnRH analogue; pain recurrence

Indexed keywords

CA 125 ANTIGEN; DIENOGEST PLUS ESTRADIOL VALERATE; LEUPRORELIN; ESTRADIOL; ESTRADIOL VALERATE-DIENOGEST; GONADORELIN; NANDROLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; TRANSVAGINAL ECHOGRAPHY; VISUAL ANALOG SCALE; ADOLESCENT; ANALGESIA; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; ITALY; LAPAROSCOPY; MIDDLE AGED; PAIN MEASUREMENT; PELVIC PAIN; QUESTIONNAIRE;

ADOLESCENT; ADULT; ENDOMETRIOSIS; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; ITALY; LAPAROSCOPY; MIDDLE AGED; NANDROLONE; PAIN MANAGEMENT; PAIN MEASUREMENT; PELVIC PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE;

EID: 84929144545     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12633     Document Type: Article

References (40)

1. Gentilini D, Perino A, Viganò P, Chiodo I, Cucinella G, Vignali M, et al. Gene expression profiling of peripheral blood mononuclear cells in endometriosis identifies genes altered in non-gynaecologic chronic inflammatory diseases. Hum Reprod. 2011; 26: 3109-17.
2. Morelli M, Sacchinelli A, Venturella R, Mocciaro R, Zullo F,. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients. J Obstet Gynaecol Res. 2013; 39: 985-90.
3. Fauconnier A, Chapron C,. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005; 11: 595-606.
4. Granese R, Candiani M, Perino A, Venezia R, Cucinella G,. Bladder endometriosis: laparoscopic treatment and follow-up. Eur J Obstet Gynecol Reprod Biol. 2008; 140: 114-7.
5. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C,. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010; 25: 633-41.
6. Muzii L, Marana R, Angioli R, Bianchi A, Cucinella G, Vignali M, et al. Histologic analysis of specimens from laparoscopic endometrioma excision performed by different surgeons: does the surgeon matter? Fertil Steril. 2011; 95: 2116-9.
7. Vercellini P, Somigliana E, Viganò P, De Matteis S, Barbara G, Fedele L,. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010; 21: 259-65.
8. Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG,. Post-operative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008; 198: 504.e1-5.
9. Weir E, Mustard C, Cohen M, Kung R,. Endometriosis: what is the risk of hospital admission, readmission, and major surgical intervention? J Minim Invasive Gynecol. 2005; 12: 486-93.
10. Cheong Y, Tay P, Luk F, Gan HC, Li TC, Cooke I,. Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol. 2008; 28: 82-5.
11. Hachisuga T, Kawarabayashi T,. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod. 2002; 17: 432-5.
12. Cucinella G, Granese R, Calagna G, Svelato A, Saitta S, Tonni G, et al. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? Arch Gynecol Obstet. 2013; 288: 821-7.
13. Donnez J, Pirard C, Smets M, Jadoul P, Squifflet J,. Surgical management of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004; 18: 329-48.
14. Batzer FR,. GnRH analogs: options for endometriosis-associated pain treatment. J Minim Invasive Gynecol. 2006; 13: 539-45.
15. Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Baranao RI,. Effect of GnRH analogues on apoptosis and release of interleukin-1b and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod. 2005; 18: 1767-71.
16. Dlugi AM, Miller JD, Knittle J,. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. Fertil Steril. 1990; 54: 419-27.
17. Parazzini F, Di Cintio E, Chatenoud L, Moroni S, Ardovino I, Struzziero E, et al. Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2000; 88: 11-4.
18. Schindler AE,. Dienogest in long-term treatment of endometriosis. Int J Womens Health. 2011; 3: 175-84.
19. McCormack PL,. Dienogest: a review of its use in the treatment of endometriosis. Drugs. 2010; 70: 2073-88.
20. Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012; 285: 167-73.
21. Gerlinger C, Schumacher U, Faustmann T, Colligs A, Schmitz H, Seitz C,. Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials. Health Qual Life Outcomes. 2010; 8: 13.
22. Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008; 90 (5 Suppl.): S260-9.
23. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67: 817-21.
24. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB,. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993; 60: 776-80.
25. Savelli L,. Transvaginal sonography for the assessment of ovarian and pelvic endometriosis: how deep is our understanding? Ultrasound Obstet Gynecol. 2009; 33: 497-501.
26. Garry R,. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol. 2004; 16: 299-303.
27. Takae S, Kawamura K, Sato Y, Nishijima C, Yoshioka N, Sugishita Y, et al. Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency. PLoS ONE. 2014; 23: e98174.
28. ACOG Committee on Practice Bulletins-Gynaecology. ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces technical bulletin number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000; 71: 183-96.
29. Thomas EJ,. Combining medical and surgical treatment for endometriosis: the best of both worlds? BJOG. 1992; 99 (Suppl. 7): 5-8.
30. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29: 400-12.
31. Oettel M, Breitbarth H, Elger W, Gräser T, Hübler D, Kaufmann G, et al. The pharmacological profile of dienogest. Eur J Contracept Reprod Health Care. 1999; 4 (1 Suppl.): 2-13.
32. Vercellini P, Frattaruolo MP, Somigliana E, Jones GL, Consonni D, Alberico D, et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod. 2013; 28: 1221-30.
33. Sesti F, Pietropolli A, Capozzolo T, Broccoli P, Pierangeli S, Bollea MR, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial. Fertil Steril. 2007; 88: 1541-7.
34. Rodgers AK, Falcone T,. Treatment strategies for endometriosis. Expert Opin Pharmacother. 2008; 9: 243-55.
35. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG,. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003; 9: 387-96.
36. Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Savelli L, Venturoli S,. Long-term oralcontraceptive pills and postoperativepain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010; 94: 464-71.
37. Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P,. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. BJOG. 1999; 106: 672-7.
38. Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S,. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril. 2011; 95: 492-6.
39. Davis L, Kennedy SS, Moore J, Prentice A,. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2007; 3: CD001019.
40. Vignali M, Bianchi S, Candiani M, Spadaccini G, Oggioni G, Busacca M,. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005; 12: 508-13.